A Study of GSK256073 in Subjects With Type 2 Diabetes Mellitus Who Are Being Treated With Metformin

Update Il y a 4 ans
Reference: NCT01376323

Woman and Man

Extract

The aim of this combined, two part study is to evaluate the safety and glucose lowering effects of GSK256073 when administered to diabetic subjects for 12 weeks.


Inclusion criteria

  • Diabetes Mellitus, Type 2


Links